<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The current study aimed to investigate whether <z:mp ids='MP_0002959'>microalbuminuria</z:mp> or moderately decreased glomerular filtration rate (GFR) is a better predictor for the development and progression of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Type 2 diabetic patients without <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, pregnancy, and <z:hpo ids='HP_0011009'>acute</z:hpo> intercurrent illness were enrolled between 1 August 2001 and 31 December 2002 </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> participants provided their detailed medical history and underwent an eye fundus examination </plain></SENT>
<SENT sid="3" pm="."><plain>They were followed up in outpatient clinics, and serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, urinary albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (UACR), and <z:chebi fb="46" ids="15035">retinal</z:chebi> photographs were followed up annually until 31 December 2009 </plain></SENT>
<SENT sid="4" pm="."><plain>The primary outcomes were development and progression of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The secondary outcomes were cardiovascular events and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Among 487 participants, 81 subjects had normoalbuminuria and moderate <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> (baseline eGFR 30-59.9 mL/min/1.73 m(2)), and 106 subjects had <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and baseline eGFR ≥60 mL/min/1.73 m(2) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and eGFR ≥60 mL/min/1.73 m(2) had a significantly greater risk for development and progression of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (HR 3.34 [95% CI 1.04-10.70]) compared with those with moderate <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> and normoalbuminuria after multivariate adjustment </plain></SENT>
<SENT sid="8" pm="."><plain>Risks for renal outcome, cardiovascular events, and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality were not significantly different between the two groups </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:mp ids='MP_0002959'>Microalbuminuria</z:mp> has a greater impact on predicting the development and progression of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> compared with moderate decline in GFR among type 2 diabetic patients </plain></SENT>
</text></document>